Back to Search
Start Over
Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group.
- Source :
- Hematological Oncology; Oct2022, Vol. 40 Issue 4, p801-804, 4p
- Publication Year :
- 2022
- Subjects :
- HODGKIN'S disease
BRUTON tyrosine kinase
Subjects
Details
- Language :
- English
- ISSN :
- 02780232
- Volume :
- 40
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Hematological Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159614478
- Full Text :
- https://doi.org/10.1002/hon.2986